Behnam Moein Jahromi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Behnam Moein Jahromi has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Ali Noorafshan
Histomorphometry and Stereology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
4 shared publications - Mansooreh Bagheri
Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz
3 shared publications - Ali Zamani
Department of Internal Medicine, Endocrine and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 shared publications - Gholamhossein Ranjbar Omrani
Shiraz Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 shared publications - Hossein Mirkhani
Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
2 shared publications Zhabiz Solhjou
Cell and Molecular Medicine Research Group, Student Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 shared publications
Latest Publications
- 22 October 2018
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 89 (2) , 436-437
Small-bowel hemangioma: rare and hard to find
- 22 October 2018
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 89 (2) , 436-437
Small-bowel hemangioma: rare and hard to find
- 12 April 2018
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 17 (8) , A41-A42
Metastatic Cervical Cancer Causing Esophageal Compression and Dysphagia
- 12 April 2018
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 17 (8) , A41-A42
Metastatic Cervical Cancer Causing Esophageal Compression and Dysphagia
- 1 August 2014
- Vol. 149 (4) , 427-433
Effect of intradermal injection of heparinase III on skin wound healing in diabetic rats
Aim. Impaired wound healing is a major complication of diabetes. It is mainly attributed to neuropathy and vascular damage in this disease. Heparanase is an endoglycosidase that degrades heparan sulfate in the extracellular matrix and is believed to promote angiogenesis. The present study has been performed to investigate the effect of heparinase III (an enzyme which exclusively cleaves heparan sulfate) on wound healing in diabetic rats. Methods. The rats became diabetic by a single streptozotocin injection. Two weeks later, a wound was created by excision of the skin in the left paravertebral area. Heparinase III (0.2 unit) was injected intradermally around the wound every 5 days, starting on day one, for a total of three doses. The wound area was measured every 3 days. After completion of wound healing, full thickness skin samples were taken from the wound sites and evaluated for volume density of the collagen bundles, numerical density of the fibroblasts, and length density of the vessels. Results. Heparinase III accelerated wound closure compared to control diabetic animals. Microscopical examination revealed that it increased angiogenesis with no significant effect on collagen density and the number of fibroblasts. Conclusion. Heparinase III induces angiogenesis and improves wound healing in diabetic animal model.
- 1 August 2014
- Vol. 149 (4) , 427-433
Effect of intradermal injection of heparinase III on skin wound healing in diabetic rats
Aim. Impaired wound healing is a major complication of diabetes. It is mainly attributed to neuropathy and vascular damage in this disease. Heparanase is an endoglycosidase that degrades heparan sulfate in the extracellular matrix and is believed to promote angiogenesis. The present study has been performed to investigate the effect of heparinase III (an enzyme which exclusively cleaves heparan sulfate) on wound healing in diabetic rats. Methods. The rats became diabetic by a single streptozotocin injection. Two weeks later, a wound was created by excision of the skin in the left paravertebral area. Heparinase III (0.2 unit) was injected intradermally around the wound every 5 days, starting on day one, for a total of three doses. The wound area was measured every 3 days. After completion of wound healing, full thickness skin samples were taken from the wound sites and evaluated for volume density of the collagen bundles, numerical density of the fibroblasts, and length density of the vessels. Results. Heparinase III accelerated wound closure compared to control diabetic animals. Microscopical examination revealed that it increased angiogenesis with no significant effect on collagen density and the number of fibroblasts. Conclusion. Heparinase III induces angiogenesis and improves wound healing in diabetic animal model.
- Open Access
- 19 August 2011
- Published by Wiley in International Wound Journal
- Vol. 8 (6) , 658-660
Folic acid may be a potential addition to diabetic foot ulcer treatment - a hypothesis
Delayed wound healing in diabetes is a challenging medical and societal problem for which there is currently no efficacious treatment. One of the major contributors of this problem is nitric oxide (NO) deficiency. NO is a critical signalling molecule essential for normal wound repair. Sustained hyperglycaemia in diabetes leads to increased vascular superoxide production, which inactivates NO and causes vascular dysfunction. New therapeutic regiments and strategies to enhance endothelial NO production are a new hope to improve impaired diabetic wound healing. One of the agents that have the ability to improve endothelial NO generation in diabetic patients is folic acid. Folic acid ability to conserve NO bioactivity may be due to homocysteine-lowering effects of folates, antioxidant actions and effects on cofactor availability. Considering these data, we hypothesised that folic acid supplementation may ameliorate delayed diabetic wound healing by increasing NO bioavailability. The potential of exogenous folic acid as an inexpensive and safe oral therapy stimulates ongoing investigations.
- 19 August 2011
- Published by Wiley in International Wound Journal
- Vol. 8 (6) , 658-660
Open AccessFolic acid may be a potential addition to diabetic foot ulcer treatment - a hypothesis
Delayed wound healing in diabetes is a challenging medical and societal problem for which there is currently no efficacious treatment. One of the major contributors of this problem is nitric oxide (NO) deficiency. NO is a critical signalling molecule essential for normal wound repair. Sustained hyperglycaemia in diabetes leads to increased vascular superoxide production, which inactivates NO and causes vascular dysfunction. New therapeutic regiments and strategies to enhance endothelial NO production are a new hope to improve impaired diabetic wound healing. One of the agents that have the ability to improve endothelial NO generation in diabetic patients is folic acid. Folic acid ability to conserve NO bioactivity may be due to homocysteine-lowering effects of folates, antioxidant actions and effects on cofactor availability. Considering these data, we hypothesised that folic acid supplementation may ameliorate delayed diabetic wound healing by increasing NO bioavailability. The potential of exogenous folic acid as an inexpensive and safe oral therapy stimulates ongoing investigations.
- 1 August 2011
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 93 (2) , 228-234
Adipose tissue derived mesenchymal stem cell (AD-MSC) promotes skin wound healing in diabetic rats
- 1 August 2011
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 93 (2) , 228-234
Adipose tissue derived mesenchymal stem cell (AD-MSC) promotes skin wound healing in diabetic rats
- 1 July 2011
- Published by Elsevier in Journal of Surgical Research
- Vol. 169 (1) , e101-e107
Azelnidipine, a New Calcium Channel Blocker, Promotes Skin Wound Healing in Diabetic Rats
- 1 July 2011
- Published by Elsevier in Journal of Surgical Research
- Vol. 169 (1) , e101-e107
Azelnidipine, a New Calcium Channel Blocker, Promotes Skin Wound Healing in Diabetic Rats
- 1 August 2010
- Vol. 32 (4)
A pilot study on lipolytic effect of subcutaneous botulinum toxin injection in rabbits.
To determine whether botulinum toxin type A (BTX-A) exerts a lipolytic effect by interfering with acetylcholine transmission at the cholinergic parasympathetic nerve endings.
- 1 August 2010
- Vol. 32 (4)
A pilot study on lipolytic effect of subcutaneous botulinum toxin injection in rabbits.
To determine whether botulinum toxin type A (BTX-A) exerts a lipolytic effect by interfering with acetylcholine transmission at the cholinergic parasympathetic nerve endings.
- 15 March 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (5) , 1388-1393
Preventive role of exogenous testosterone on cisplatin-induced gonadal toxicity: an experimental placebo-controlled prospective trial
- 15 March 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (5) , 1388-1393
Preventive role of exogenous testosterone on cisplatin-induced gonadal toxicity: an experimental placebo-controlled prospective trial